I am working up a rather longish historical survey of several astonishingly “coincidental” timeline-intersections — related to the aggressive marketing, regular SEC-filed safety reassurances, and ultimately, the abrupt withdrawals of various COX inhibitors — primarily Celebrex®, Bextra® and Vioxx®. The first two were brought to market by Fred Hassan and Carrie S. Cox, while still at Pharmacia — the last by prior management at legacy Merck. Of course, Fred and Carrie went on to an ignomious “Act II” — at legacy Schering-Plough (which is now “New” Merck).
I think you’ll find it fascinating. Bear with me as I generate several graphics depicting these three notorious drugs — and do look for that post either later tonight, or sometime on the 29th or 30th — as my holiday duties subside.